Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PBDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CYR61 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMTA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ING1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JUN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP2R1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CCZ1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUPT4H1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATG101 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CADPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF103-CHMP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP2S1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STYXL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTATIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MLLT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on